These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31423433)

  • 1. Correlation between intracoronary thrombus components and coronary blood flow after percutaneous coronary intervention for acute myocardial infarction at different onset time.
    Zhang MJ; Liu X; Liu LH; Li N; Zhang N; Wang YQ; Sun XJ; Huang PH; Yin HM; Liu YH; Zheng H
    World J Clin Cases; 2019 Aug; 7(15):2013-2021. PubMed ID: 31423433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.
    Dong-bao L; Qi H; Zhi L; Shan W; Wei-ying J
    Clin Cardiol; 2010 Dec; 33(12):E7-12. PubMed ID: 21184547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention.
    Zhou H; He XY; Zhuang SW; Wang J; Lai Y; Qi WG; Yao YA; Liu XB
    World J Emerg Med; 2014; 5(2):96-102. PubMed ID: 25215156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
    Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
    Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Clinical and Procedural Predictive Factors of no-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention.
    Abdi S; Rafizadeh O; Peighambari M; Basiri H; Bakhshandeh H
    Res Cardiovasc Med; 2015 May; 4(2):e25414. PubMed ID: 26393231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.
    Yip HK; Chen MC; Chang HW; Hang CL; Hsieh YK; Fang CY; Wu CJ
    Chest; 2002 Oct; 122(4):1322-32. PubMed ID: 12377860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction.
    Zhou SS; Tian F; Chen YD; Wang J; Sun ZJ; Guo J; Jin QH
    J Geriatr Cardiol; 2015 Mar; 12(2):135-42. PubMed ID: 25870616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
    JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of optimized thrombus aspiration on myocardial perfusion and prognosis in acute ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention.
    Xu B; Zhang C; Wei W; Zhan Y; Yang M; Wang Y; Zhao J; Lin G; Zhang WW; Huo X; Shi B; Fan L
    Front Cardiovasc Med; 2023; 10():1249924. PubMed ID: 37859682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shock Index on Admission Is Associated with Coronary Slow/No Reflow in Patients with Acute Myocardial Infarction Undergoing Emergent Percutaneous Coronary Intervention.
    Wang Q; Shen H; Mao H; Yu F; Wang H; Zheng J
    J Interv Cardiol; 2019; 2019():7873468. PubMed ID: 31772546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction.
    Li J; Wu L; Tian X; Zhang J; Shi Y
    PLoS One; 2015; 10(6):e0119223. PubMed ID: 26035818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction.
    Hang CL; Wang CP; Yip HK; Yang CH; Guo GB; Wu CJ; Chen SM
    Chest; 2005 Oct; 128(4):2593-8. PubMed ID: 16236929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Administration of Intracoronary Nitroprusside Compared with Thrombus Aspiration in Myocardial Perfusion for Acute Myocardial Infarction: A 3-Year Clinical Follow-Up Study.
    Lee WC; Chen SM; Liu CF; Chen CJ; Chung WJ; Hsueh SK; Tsai TH; Fang HY; Yip HK; Hang CL
    Acta Cardiol Sin; 2015 Sep; 31(5):373-80. PubMed ID: 27122896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of intracoronary nitroprusside injection on flow recovery during primary PCI in acute STEMI patients.
    Yang L; Mu L; Sun L; Qi F; Guo R
    Minerva Cardioangiol; 2017 Apr; 65(2):111-118. PubMed ID: 27249789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictors of the no-reflow phenomenon after primary percutaneous coronary intervention for acute myocardial infarction].
    Zhao Y; Chen Y; Tian F; Wang C; Hu S; Wang J; Yang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):261-4. PubMed ID: 22381773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between visible thrombus aspiration material with no-reflow and in-hospital mortality ratio in patients with anterior ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Şeker T; Türkoğlu C; Akkuş O; Gür M
    Turk Kardiyol Dern Ars; 2019 Mar; 47(2):95-102. PubMed ID: 30874511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study.
    Singh R; Singla SK; Singla A; Manchanda S; Kaur M
    Int J Appl Basic Med Res; 2022; 12(4):260-264. PubMed ID: 36726658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.